2-231062311-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002807.4(PSMD1):c.124G>A(p.Val42Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,607,104 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002807.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PSMD1 | NM_002807.4 | c.124G>A | p.Val42Ile | missense_variant | 3/25 | ENST00000308696.11 | |
PSMD1 | NM_001191037.2 | c.124G>A | p.Val42Ile | missense_variant | 3/24 | ||
PSMD1 | XM_017004517.3 | c.124G>A | p.Val42Ile | missense_variant | 3/18 | ||
PSMD1 | NR_034059.2 | n.283G>A | non_coding_transcript_exon_variant | 3/24 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PSMD1 | ENST00000308696.11 | c.124G>A | p.Val42Ile | missense_variant | 3/25 | 1 | NM_002807.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152160Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000241 AC: 6AN: 249270Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 134960
GnomAD4 exome AF: 0.0000186 AC: 27AN: 1454944Hom.: 0 Cov.: 29 AF XY: 0.0000221 AC XY: 16AN XY: 724108
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152160Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74324
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 21, 2023 | The c.124G>A (p.V42I) alteration is located in exon 3 (coding exon 3) of the PSMD1 gene. This alteration results from a G to A substitution at nucleotide position 124, causing the valine (V) at amino acid position 42 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at